Synaptogenix

SNPX59

Penny Stock

$2.61arrow_drop_up8.75%$0.20

Penny Stock

SNPX59

$2.61

arrow_drop_up8.75%$0.20

Penny Stock

Performance History

Key Stats
Open	$2.61
Prev. Close	$2.61
EPS	10.27
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$3.25M

	LOW	HIGH
Day Range	2.34	2.61
52 Week Range	2.34	10.25

Ratios

Revenue	-



EBITDA Margin %	-

EPS	10.27

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Synaptogenix (SNPX)

Synaptogenix, Inc. (SNPX) is a biotechnology company focused on developing innovative therapeutics for the treatment of Alzheimer's disease. The company's primary focus is on the development of its lead drug candidate, Bryostatin-1, which has shown promising results in preclinical studies. Bryostatin-1 is a potent protein kinase C (PKC) activator that has been shown to enhance memory and cognitive function in animal models of Alzheimer's disease.

The history of SNPX stock price has been volatile, with significant fluctuations over the past few years. The stock has experienced both periods of growth and declines, reflecting the uncertainty surrounding the development of Bryostatin-1. Investors should carefully consider the risks and potential rewards before investing in SNPX.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Alan J. Tuchman M.D., MBA(FAAN)
Headquarters: New York
Employees: 5
Exchange: NASDAQ

Keep an eye on Synaptogenix

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Synaptogenix's (SNPX) price per share?

The current price per share for Synaptogenix (SNPX) is $2.62. The stock has seen a price change of $0.21 recently, indicating a 8.75% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Synaptogenix (SNPX)?

For Synaptogenix (SNPX), the 52-week high is $10.25, which is 291.97% from the current price. The 52-week low is $2.35, the current price is 11.47% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Synaptogenix (SNPX) a growth stock?

Synaptogenix (SNPX) has shown an average price growth of -6.8% over the past three years. It has received a score of 96 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Synaptogenix as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Synaptogenix (SNPX) stock price performance year to date (YTD)?

As of the latest data, Synaptogenix (SNPX) has a year-to-date price change of -64.51%. Over the past month, the stock has experienced a price change of -15.92%. Over the last three months, the change has been -26.75%. Over the past six months, the figure is -44.95%.

help

Is Synaptogenix (SNPX) a profitable company?

Synaptogenix (SNPX) has a net income of -$6.04M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$8.31M. Furthermore, the EBITDA is -$6.83M.

help

What is the market capitalization of Synaptogenix (SNPX)?

Synaptogenix (SNPX) has a market capitalization of $3.25M. The average daily trading volume is 2.6, indicating the stock's liquidity and investor engagement.